Skip to main content

Celeris Therapeutics

Menlo Park, United States

Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.

$9.8M raised
Oct 2022
Venture - Series Unknown

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Celeris Therapeutics

How much funding has Celeris Therapeutics raised?
Celeris Therapeutics has raised $9.8M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2022.
Who are Celeris Therapeutics's investors?
Celeris Therapeutics's investors include European Innovation Council, R42 Group, Longevitytech.fund, APEX Ventures, Pace Ventures.
Where is Celeris Therapeutics headquartered?
Celeris Therapeutics is headquartered in Menlo Park, United States.
What does Celeris Therapeutics do?
Harnessing deep learning and lab automation to accelerate drug discovery in targeted protein degradation.
What stage is Celeris Therapeutics at?
Celeris Therapeutics is at the Venture - Series Unknown stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Celeris Therapeutics — Funding & Investors." VCBacked, October 19, 2022, https://www.vcbacked.co/company/celeris-therapeutics. Accessed July 2, 2026.
APA
VCBacked. (2022). Celeris Therapeutics — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/celeris-therapeutics
Wikipedia (cite web)
{{cite web |title=Celeris Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/celeris-therapeutics |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .